Kozak & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8K | Hold |
25
| – | – | ﹤0.01% | 194 |
|
|
2025
Q1 | $19K | Hold |
25
| – | – | ﹤0.01% | 176 |
|
|
2024
Q4 | $19.6K | Buy |
25
+10
| +67% | +$7.86K | ﹤0.01% | 182 |
|
|
2024
Q3 | $14.1K | Hold |
15
| – | – | ﹤0.01% | 208 |
|
|
2024
Q2 | $13.8K | Sell |
15
-1
| -6% | -$921 | ﹤0.01% | 204 |
|
|
2024
Q1 | $12.1K | Buy |
16
+1
| +7% | +$759 | ﹤0.01% | 219 |
|
|
2023
Q4 | $9.73K | Sell |
15
-7
| -32% | -$4.54K | ﹤0.01% | 237 |
|
|
2023
Q3 | $12.6K | Buy |
22
+15
| +214% | +$8.59K | ﹤0.01% | 218 |
|
|
2023
Q2 | $3.36K | Hold |
7
| – | – | ﹤0.01% | 285 |
|
|
2023
Q1 | $2.49K | Hold |
7
| – | – | ﹤0.01% | 294 |
|
|
2022
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 290 |
|
|
2022
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 301 |
|
|
2022
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 338 |
|
|
2022
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 351 |
|
|
2021
Q4 | $2K | Hold |
7
| – | – | ﹤0.01% | 351 |
|
|
2021
Q3 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 306 |
|